← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2016Last known activity
Jan 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 3 (5 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT05550402Lead sponsorPhase 3Jan 1, 2023
- NCT05550402Reponsible party - principal investigatorPhase 3Jan 1, 2023
- NCT05550402Sponsor investigatorPhase 3Jan 1, 2023
- NCT04215848Reponsible party - principal investigatorPhase 3Jan 1, 2020
- NCT04215848Lead sponsorPhase 3Jan 1, 2020
- NCT02806141Lead sponsorPhase 3Sep 1, 2016
- NCT02806141Overall official - principal investigatorPhase 3Sep 1, 2016
- NCT02806141Reponsible party - principal investigatorPhase 3Sep 1, 2016
- NCT02725242Reponsible party - principal investigatorPhase 3Mar 1, 2016
- NCT02725242Lead sponsorPhase 3Mar 1, 2016
Details
- Last known activity
- Jan 1, 2023